These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26838175)

  • 1. Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.
    Quehl P; Hollender J; Schüürmann J; Brossette T; Maas R; Jose J
    Microb Cell Fact; 2016 Feb; 15():26. PubMed ID: 26838175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the activity of surface displayed cytochrome P450 enzymes by optimizing the outer membrane linker.
    Quehl P; Schüürmann J; Hollender J; Jose J
    Biochim Biophys Acta Biomembr; 2017 Jan; 1859(1):104-116. PubMed ID: 27814979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Phenacetin Oxidation upon the L382V Substitution in Cytochrome P450 1A2 is Associated with Altered Substrate Binding Orientation.
    Huang Q; Szklarz GD
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29799514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli.
    Vail RB; Homann MJ; Hanna I; Zaks A
    J Ind Microbiol Biotechnol; 2005 Feb; 32(2):67-74. PubMed ID: 15739102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2.
    Davydova NY; Dangi B; Maldonado MA; Vavilov NE; Zgoda VG; Davydov DR
    Biochem J; 2019 Dec; 476(23):3661-3685. PubMed ID: 31750875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme.
    Sandhu P; Guo Z; Baba T; Martin MV; Tukey RH; Guengerich FP
    Arch Biochem Biophys; 1994 Feb; 309(1):168-77. PubMed ID: 8117105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism.
    Liu J; Ericksen SS; Sivaneri M; Besspiata D; Fisher CW; Szklarz GD
    Arch Biochem Biophys; 2004 Apr; 424(1):33-43. PubMed ID: 15019834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
    Parikh A; Guengerich FP
    Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytochrome P450 expression in bacteria: Whole-cell high-throughput activity assay for CYP1A2, 2A6 and 3A4.
    Esteves F; Campelo D; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
    Biochem Pharmacol; 2018 Dec; 158():134-140. PubMed ID: 30308189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.
    Reed JR; dela Cruz AL; Lomnicki SM; Backes WL
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):223-30. PubMed ID: 26423927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
    Shiota N; Kodama S; Inui H; Ohkawa H
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli.
    Kim DH; Kim KH; Isin EM; Guengerich FP; Chae HZ; Ahn T; Yun CH
    Protein Expr Purif; 2008 Feb; 57(2):188-200. PubMed ID: 18032064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression in Bacillus subtilis of mammalian NADPH-cytochrome P450 oxidoreductase and its spore-display.
    Yim SK; Jung HC; Yun CH; Pan JG
    Protein Expr Purif; 2009 Jan; 63(1):5-11. PubMed ID: 18678259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450.
    Campelo D; Esteves F; Brito Palma B; Costa Gomes B; Rueff J; Lautier T; Urban P; Truan G; Kranendonk M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of 20 allelic variants of CYP1A2.
    Ito M; Katono Y; Oda A; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2015 Jun; 30(3):247-52. PubMed ID: 26022657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of active human P450 3A4 on the cell surface of Escherichia coli by Autodisplay.
    Schumacher SD; Jose J
    J Biotechnol; 2012 Oct; 161(2):113-20. PubMed ID: 22326629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding.
    Kim D; Guengerich FP
    Arch Biochem Biophys; 2004 Dec; 432(1):102-8. PubMed ID: 15519301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
    Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.